These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37226638)

  • 1. Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma.
    Kawamura K; Miyai K; Sato K; Matsukuma S; Honda K; Ito K; Tsuda H
    Cancer Sci; 2023 Aug; 114(8):3411-3422. PubMed ID: 37226638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor budding in upper urinary tract urothelial carcinoma: a putative prognostic factor for extraurothelial recurrence and overall survival.
    Kawamura K; Miyai K; Asakuma J; Sato K; Matsukuma S; Tsuda H; Ito K
    Virchows Arch; 2021 Jul; 479(1):45-55. PubMed ID: 33404852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.
    Yamamoto Y; Oga A; Akao J; Misumi T; Fuji N; Kobayashi K; Kawai Y; Inoue R; Hirata H; Matsumoto H; Nagao K; Sakano S; Matsuyama H
    Jpn J Clin Oncol; 2016 Aug; 46(8):754-61. PubMed ID: 27174960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance.
    Yamamoto S; Tsuda H; Honda K; Onozato K; Takano M; Tamai S; Imoto I; Inazawa J; Yamada T; Matsubara O
    Mod Pathol; 2009 Apr; 22(4):499-507. PubMed ID: 19151661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma.
    Miyai K; Kawamura K; Ito K; Matsukuma S; Tsuda H
    BMC Cancer; 2022 Jul; 22(1):787. PubMed ID: 35850759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.
    Noro R; Honda K; Tsuta K; Ishii G; Maeshima AM; Miura N; Furuta K; Shibata T; Tsuda H; Ochiai A; Sakuma T; Nishijima N; Gemma A; Asamura H; Nagai K; Yamada T
    Ann Oncol; 2013 Oct; 24(10):2594-2600. PubMed ID: 23899839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma.
    Watabe Y; Mori T; Yoshimoto S; Nomura T; Shibahara T; Yamada T; Honda K
    Cancer Med; 2014 Jun; 3(3):613-22. PubMed ID: 24574362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.
    Kakuya T; Mori T; Yoshimoto S; Watabe Y; Miura N; Shoji H; Onidani K; Shibahara T; Honda K
    Int J Oral Maxillofac Surg; 2017 Aug; 46(8):968-976. PubMed ID: 28385383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
    Nishikawa M; Miyake H; Fujisawa M
    Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
    Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
    J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
    Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
    Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Yamashita R; Watanabe R; Ito I; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
    Int Urol Nephrol; 2017 Mar; 49(3):425-430. PubMed ID: 28078533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Morizane S; Iwamoto H; Masago T; Yao A; Isoyama T; Sejima T; Takenaka A
    Int Urol Nephrol; 2013 Feb; 45(1):99-106. PubMed ID: 23229166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.
    Cheaib JG; Claus LE; Patel HD; Kates MR; Matoso A; Hahn NM; Bivalacqua TJ; Hoffman-Censits JH; Pierorazio PM
    Urol Oncol; 2021 Jan; 39(1):74.e9-74.e16. PubMed ID: 33071108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.